New Treatment for Schizophrenia – From a Common Anti-Acid Medication
Schizophrenia is a serious, debilitating psychiatric disorder that affects millions of individuals worldwide. The causes of Schizophrenia are a multitude of biochemical and neurochemical imbalances that affect not only adults, but teangers and children.
Treatment for Schizophrenia is often problematic and ineffective. New research brings to the forefront hope for some with Schizophrenia via a common antacid medication called Pepcid. Pepcid, given at much larger dosages compared to what is used for acid suppression, has shown in a recent study to be helpful for Schizophrenia.
Famotidine has been used for the treatment of heartburn since the 1980s, but at regular dosing, famotidine almost does not enter the brain at all, since the brain is protected by the blood-brain barrier. By increasing the dosage five-fold the drug is able to enter the brain and affect the histamine system (read more)